We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Novel Inflator Suitable for Multiple Interventional Balloon Systems

By HospiMedica International staff writers
Posted on 15 Jul 2013
Print article
Image: The basixTOUCH high-pressure balloon inflator (Photo courtesy of Merit Medical).
Image: The basixTOUCH high-pressure balloon inflator (Photo courtesy of Merit Medical).
A novel high-pressure syringe for use in catheterization laboratories could potentially replace multiple inflation systems by offering a wide range of available pressure.

The basixTOUCH high-pressure balloon inflator delivers pressure of up to 3546 kPa (or 35 atmospheres) for inflating an angioplasty balloon or other interventional device, continuously measuring the pressure within the balloon. Once the intervention has ended, the balloon can be quickly deflated, dropping the pressure rapidly thanks to a quick-release handle. The system can be prepped and primed single-handedly, and eliminates the need to use multiple inflation devices in some advanced interventional cases, thanks to its high-pressure range.

Two important features of the device include an ergonomic handle and threads that ensure high pressures can be reached rapidly, reaching maximum with less than three clockwise rotations of the handle. The system is supplied with a 30 mL syringe barrel that accommodates additional fluid for large balloons. The basixTOUCH high-pressure balloon inflator is a product of Merit Medical (South Jordan, UT, USA), and has been approved by the US Food and Drug Administration (FDA).

“We believe the introduction of the basixTOUCH clearly places Merit in the worldwide leadership position for inflation devices which are used in numerous interventional and peripheral procedures,” said Fred Lampropoulos, chairman and CEO of Merit Medical. “This device and its derivatives have the potential, when combined with other devices such as our hemostasis valves, to become the largest single revenue producing product in Merit’s history.”

Related Links:
Merit Medical


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Electric Bariatric Patient Lifter
SVBL 205

Print article

Channels

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.